UNCLAIMED
Atorus
Overview
Atorus is a United States-based company founded in 2020, operating within the Business Services industry, specifically in Research and Development. The company employs between 201 and 500 individuals and reported revenue of approximately $48.99 million. Atorus is focused on advancing open-source technologies in clinical research, as evidenced by its contributions to various consortia, including PHUSE, PharmaSUG, CDISC, R/Pharma, R Validation Hub, and R Consortium. The company's primary offering is OpenVal®, a framework designed for users in validated or Good Practice (GxP) compliant environments, which supports both novice and expert R users. OpenVal® facilitates the adoption of R programming by providing a code-based execution environment that integrates with existing IT, Quality Assurance, and Operations departments. The framework aims to enhance data analytics capabilities through interactive web applications and offers a subscription model that includes validated installations, major release updates, and product support. Atorus emphasizes the flexibility and transparency of open-source solutions while aiming to streamline processes in clinical programming and data analysis.